Exposure to ultrafine particles and cognitive decline among older people in the United States
- PMID: 36965813
- PMCID: PMC10246447
- DOI: 10.1016/j.envres.2023.115768
Exposure to ultrafine particles and cognitive decline among older people in the United States
Abstract
Background: Some studies suggest that ambient particulate air pollution is associated with cognitive decline. However, the findings are mixed, and there is no relevant research examining the influences of ultrafine particles (UFP), which may have more toxicity than larger particles. We therefore conducted this study to investigate whether residential UFP exposure is associated with cognitive decline using data from the Alzheimer's Disease Research Centers in the United States.
Methods: This is a longitudinal study of participants who were aged 65 years and older and had normal cognitive status at baseline. Residential UFP exposure, expressed as particle number concentrations (PNC), was assessed in 2016-2017 using a nationwide land use regression model, and was assigned to each participant using their 3-digit residential ZIP codes. Cognitive functions including memory, attention, language, executive function, and global function were assessed annually using 15 neuropsychological tests from March 2015 to February 2022. Linear mixed-effects models were used to examine the associations after adjustment for covariates including baseline age, sex, APOE ε4 status, race, education, smoking status, history of diabetes, quartiles of neighborhood median household income, and interaction terms of follow-up time with each covariate.
Results: This study included 5646 participants (mean age 76 years, 65% female). On average, each participant had 4 annual visits. When PNC was treated as a continuous variable, there were no statistically or clinically significant changes in annual decline of each cognitive function in relation to an interquartile range elevation in PNC (4026 particles/cm3). Similarly, when PNC was treated as a categorical variable including five exposure groups, there were no linear exposure-response trends in annual decline of each cognitive function across the five exposure groups.
Conclusions: This study found no meaningful associations between residential UFP exposure and cognitive decline in global and domain-specific functions. There is a need for further research that assigns UFP exposure at a finer geographic scale.
Keywords: Aged; Air pollution; Cognitive dysfunction; Dementia; Longitudinal studies; Ultrafine particulate matter.
Copyright © 2023 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Air quality improvement and cognitive decline in community-dwelling older women in the United States: A longitudinal cohort study.PLoS Med. 2022 Feb 3;19(2):e1003893. doi: 10.1371/journal.pmed.1003893. eCollection 2022 Feb. PLoS Med. 2022. PMID: 35113870 Free PMC article.
-
C-reactive protein (CRP) and long-term air pollution with a focus on ultrafine particles.Int J Hyg Environ Health. 2018 Apr;221(3):510-518. doi: 10.1016/j.ijheh.2018.01.016. Epub 2018 Jan 31. Int J Hyg Environ Health. 2018. PMID: 29428699
-
Association of long-term air pollution and ambient noise with cognitive decline in the Heinz Nixdorf Recall study.Environ Pollut. 2023 Aug 15;331(Pt 1):121898. doi: 10.1016/j.envpol.2023.121898. Epub 2023 May 25. Environ Pollut. 2023. PMID: 37244536
-
Air Pollution, Ultrafine Particles, and Your Brain: Are Combustion Nanoparticle Emissions and Engineered Nanoparticles Causing Preventable Fatal Neurodegenerative Diseases and Common Neuropsychiatric Outcomes?Environ Sci Technol. 2022 Jun 7;56(11):6847-6856. doi: 10.1021/acs.est.1c04706. Epub 2022 Feb 22. Environ Sci Technol. 2022. PMID: 35193357 Review.
-
Meta-analysis on short-term exposure to ambient ultrafine particles and respiratory morbidity.Eur Respir Rev. 2020 Oct 28;29(158):200116. doi: 10.1183/16000617.0116-2020. Print 2020 Dec 31. Eur Respir Rev. 2020. PMID: 33115789 Free PMC article.
Cited by
-
Assessing the contribution of the chemical exposome to neurodegenerative disease.Nat Neurosci. 2024 May;27(5):812-821. doi: 10.1038/s41593-024-01627-1. Epub 2024 Apr 29. Nat Neurosci. 2024. PMID: 38684891
-
Associations between Ultrafine Particles and Incident Dementia in Older Adults.Environ Sci Technol. 2025 Mar 25;59(11):5443-5451. doi: 10.1021/acs.est.4c10574. Epub 2025 Mar 13. Environ Sci Technol. 2025. PMID: 40079183 Free PMC article.
-
Ultrafine particles and late-life cognitive function: Influence of stationary mobile monitoring design on health inferences.Environ Pollut. 2025 Jun 1;374:126222. doi: 10.1016/j.envpol.2025.126222. Epub 2025 Apr 10. Environ Pollut. 2025. PMID: 40221115
-
Association between Ambient Ultrafine Particles and Neurodevelopmental Delay in Preschoolers in Shanghai, China.Environ Health (Wash). 2024 Oct 1;3(1):102-110. doi: 10.1021/envhealth.4c00102. eCollection 2025 Jan 17. Environ Health (Wash). 2024. PMID: 39839251 Free PMC article.
-
Need for a Holistic Approach to Assessing Sustainable, Green, and Healthy Buildings.Environ Health (Wash). 2024 Dec 16;3(3):218-226. doi: 10.1021/envhealth.4c00161. eCollection 2025 Mar 21. Environ Health (Wash). 2024. PMID: 40144326 Free PMC article. Review.
References
-
- World Health Organization. Global status report on the public health response to dementia. Available at: https://apps.who.int/iris/bitstream/handle/10665/344701/9789240033245-en.... Accessed: May 16, 2023.
-
- World Health Organization. Dementia. Available at: https://www.who.int/news-room/fact-sheets/detail/dementia. Accessed: May 16, 2023.
-
- Tariq S, Barber PA. Dementia risk and prevention by targeting modifiable vascular risk factors. J Neurochem 2018;144:565–581. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P20 AG068053/AG/NIA NIH HHS/United States
- P30 AG066515/AG/NIA NIH HHS/United States
- P30 AG062421/AG/NIA NIH HHS/United States
- P30 AG066508/AG/NIA NIH HHS/United States
- P30 AG066519/AG/NIA NIH HHS/United States
- P30 AG072973/AG/NIA NIH HHS/United States
- P30 AG066462/AG/NIA NIH HHS/United States
- P30 AG066530/AG/NIA NIH HHS/United States
- P30 AG066509/AG/NIA NIH HHS/United States
- P20 AG068077/AG/NIA NIH HHS/United States
- P30 AG066546/AG/NIA NIH HHS/United States
- P30 AG072972/AG/NIA NIH HHS/United States
- P20 AG068082/AG/NIA NIH HHS/United States
- P30 AG072975/AG/NIA NIH HHS/United States
- P30 AG066444/AG/NIA NIH HHS/United States
- P30 AG066507/AG/NIA NIH HHS/United States
- P30 AG072946/AG/NIA NIH HHS/United States
- P30 AG066518/AG/NIA NIH HHS/United States
- P30 AG066511/AG/NIA NIH HHS/United States
- U24 AG072122/AG/NIA NIH HHS/United States
- P30 AG066512/AG/NIA NIH HHS/United States
- P30 AG072978/AG/NIA NIH HHS/United States
- P30 AG072980/AG/NIA NIH HHS/United States
- P30 AG062429/AG/NIA NIH HHS/United States
- P30 AG062422/AG/NIA NIH HHS/United States
- R01 AG079280/AG/NIA NIH HHS/United States
- P30 AG072977/AG/NIA NIH HHS/United States
- P30 AG062677/AG/NIA NIH HHS/United States
- P20 AG068024/AG/NIA NIH HHS/United States
- P30 AG072958/AG/NIA NIH HHS/United States
- P30 AG062715/AG/NIA NIH HHS/United States
- P30 AG066506/AG/NIA NIH HHS/United States
- P30 AG066468/AG/NIA NIH HHS/United States
- P30 AG072976/AG/NIA NIH HHS/United States
- P30 AG072947/AG/NIA NIH HHS/United States
- P30 AG072931/AG/NIA NIH HHS/United States
- P30 AG066514/AG/NIA NIH HHS/United States
- P30 AG072959/AG/NIA NIH HHS/United States
- R01 ES030289/ES/NIEHS NIH HHS/United States
- P30 AG072979/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous